Skip to main content

Table 5 Duration of dysesthesia and paresthesias (21 day cycles)

From: Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer

Dysesthesias

Cycle number

Median duration (days)

Percent persisting ≥ 14 days

Percent persisting ≥ 21 days

1

5

9.5%

3.2%

3

7

14.3%

6.1%

6

10.5

38.2%

17.6%

9

13.5

50%

37.5%

12

21

60%

60%

Paresthesias

Cycle number

Median duration (days)

Percent persisting ≥ 14 days

Percent persisting ≥ 21 days

1

7

19.7%

6.1%

3

12.5

35.6%

18.6%

6

14

54.3%

37%

9

= 21

86.4%

77.3%

12

= 21

83.3%

83.3%